Authors : Marium R. Patel; H. A. Ghuse

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/ykvreeax

Scribd : https://tinyurl.com/bdxv25ks

DOI : https://doi.org/10.38124/ijisrt/26jan928

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Herbal extracts have long been investigated as sources of analgesic (pain-relieving) agents. This review summarizes preclinical mechanisms, clinical evidence, safety considerations, and research gaps for several widely studied analgesic herbs: curcumin (turmeric), eugenol (clove), ginger (Zingiber officinale), Boswellia serrata, and willow bark (Salix spp.). Overall, strong preclinical evidence supports anti-inflammatory and nociception-modulating effects for these botanicals; clinical trials show promising but heterogeneous results, with limitations including variable preparations/doses and small sample sizes. Future work needs larger, well-controlled clinical trials, standardized extracts, and pharmacokinetic / pharmacodynamic characterization. Substances employed for relieving pain but not causing unconsciousness are analgesics. The term analgesic comes from ancient Greek roots: "an-" means without, while "-algos" signifies pain. Medications of analgesic nature influence different parts of the brain and spinal cord as well as other nerve tissues throughout the body. Different types of pain relievers include both artificial ones such as opioid medications derived from plants like Aloe vera, licorice root, ginger rhizome, cinnamon leaf, boswellia resin, willow bark (from Salix species), and various herbal extracts containing compounds known for their anti-inflammatory properties. Furthermore. The critique provides insights into various pain-relieving substances derived from nature.

Keywords : Herbal Analgesic, Plant-Based Pain Relief, Medicinal Plants – Glycyrrhiza Glabra, Zingiber Officinale Analgesic, Eugenia Caryophyllata, Withania Somnifera, Matricaria Pubescens, Ocimum Sanctum, Boswellia Serrata, and Willow Bark.

References :

1. Vane JR, Botting RM. Mechanism of action of NSAIDs. Am J Med. 1998;104(3A):2S-8S.
2. Ernst E. Herbal medicines in pain management. Pain. 2007;127(3):185-187.
3. Calixto JB. Efficacy, safety, quality control of herbal medicines. J Ethnopharmacol. 2000;72(1-2):1-16.
4. Theken KN, (2018); variability in Analgesic response to non-steroidal anti-inflammatory drugs; prostaglandins and other lipid mediators; 139; 63-70 .
5. Zafar A. (2010); A review on analgesic; from natural sources; International journal of pharmaceutical & Biological archive; 1(2); 95-100.                             
6. Ray R, Kattimani S and Sharma H.K. Opium Abuse abs Its management: Global Scenaro. Page no. 1-13.
7. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin: lessons learned from clinical trials. Int J Biochem Cell Biol. 2009; 41(1):40-59.
8. Basnet P, Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice. Molecules. 2011; 16(6):4567-4598.
9. Gupta SC, et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep. 2013; 30(4):544-559.
10. Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating joint arthritis symptoms: A systematic review and meta-analysis. J Med Food. 2016; 19(8):717-729.
11. Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health. Foods. 2017; 6(10):92.
12. Sharma U, et al. Safety and efficacy of curcumin in inflammatory conditions. Phytother Res. 2017; 31(3):362-371.
13. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin: NF-κB inhibition. Int J Biochem Cell Biol. 2009; 41(1):40–59.
14. Nejad SM, Özgüneş H, Başaran N. Pharmacological and toxicological properties of eugenol. Avicenna J Phytomed. 2017; 7(4):337-349.
15. Pramod K, Ansari SH, Ali J. Eugenol: A natural compound with versatile pharmacological actions. Nat Prod Commun. 2010; 5(12):1999-2006.
16. Park SH, et al. Analgesic effects of eugenol through sodium channel blockade. Phytother Res. 2011; 25(3):345-349.
17. Daniel AN, et al. Anti-inflammatory and antinociceptive activities of eugenol essential oil. Pharm Biol. 2009;47(10):1007–1011.
18. Grzanna R, Lindmark L, Frondoza CG.                                                                        Ginger—An herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005;8(2):125–132.
19. Chrubasik S, Roufogalis BD, Müller-Ladner U. Ginger and its analgesic potential. Phytother Res. 2005;19(9):760-766.
20. Rondanelli M, et al. Ginger and pain: A systematic review of clinical trials. Nutrients. 2020;12(2):356.
21. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44(11):2531-2538.
22. Black CD, O'Connor PJ. Acute effects of dietary ginger on muscle pain induced by eccentric exercise. J Pain. 2010;11(9):894-903.
23. Ammon HP. Boswellic acids and their role in chronic inflammatory diseases. Planta Med.2006; 72(12):1100-1116.
24. Sengupta K, et al. A double-blind, randomized, placebo-controlled study of Boswellia serrata extract in osteoarthritis of the knee. Int J Med Sci. 2008;5(3):133-141.
25. Kimmatkar N, et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis.Phytomedicine. 2003;10(1):3-7.
26. Chrubasik S, et al. Effectiveness of willow bark extract for pain and inflammation. Phytother Res.2001;15(4):344-350.
27. Vlachojannis JE, et al. Willow bark extract for chronic low back pain: A randomized controlled trial. Am J Med.2000; 109(1):9-14.
28. Mishra, L. C., Singh, B. B., & Dagenais, S. (2000). Scientific basis for the therapeutic use of Withania somnifera. Alternative Medicine Review, 5(4), 334–346.
29. Kulkarni, S. K., & Dhir, A. (2008). Withania somnifera: An Indian ginseng. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(5), 1093–1105.
30. Gupta, A., & Rana, A. C. (2007). Analgesic and anti-inflammatory activity of Withania somnifera. Pharmaceutical Biology, 45(6), 432–435.
31. Jayaprakasam, B., Zhang, Y., & Nair, M. G. (2003). Inhibition of cyclooxygenase-2 by withanolides from Withania somnifera. Journal of Natural Products, 66(8), 1068–1071.
32. Singh, G., Sharma, P. K., & Dudhe, R. (2010). Biological activities of Withania somnifera. International Journal of Pharmaceutical Sciences Review and Research, 3(2), 1–5.
33. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1–7.
34. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) inhibits COX and LOX pathways. Prostaglandins Leukot Essent Fatty Acids. 1992;46(2):117–124.
35. Pramod K, Ansari SH, Ali J. Eugenol: a natural compound with anti-inflammatory and analgesic activity. Pharmacogn Rev. 2010;4(7):1–6.
36. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin: NF-κB inhibition. Int J Biochem Cell Biol. 2009;41(1):40–59.
37. Surh YJ. Anti-tumor promoting potential of selected spice ingredients through NF-κB inhibition. Food Chem Toxicol. 2002;40(8):1091–1097.
38. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell. 2002;109(Suppl):S81–S96.
39. Yang BH, et al. Eugenol blocks TRPV1 channels and reduces pain sensation. Pain. 2003;103(1–2):43–52.       
40. Dedov VN, et al. Gingerols modulate TRPA1 and TRPV1 ion channels. Br J Pharmacol. 2002;137(6):793–798.
41. Julius D. TRP channels and pain. Annu Rev Cell Dev Biol. 2013;29:355–384.
42. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105–125.
43. Reuter S, et al. Oxidative stress, inflammation, and cancer: curcumin as therapeutic agent. Free Radic Biol Med. 2010;49(11):1603–1616.
44. Ali BH, Blunden G. Pharmacological and toxicological properties of ginger. Food Chem Toxicol. 2003;41(11):1593–1600.
45. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol. 1999;57(1):1–164.
46. Vriens J, Nilius B, Vennekens R. Herbal modulation of neuronal ion channels. Trends Pharmacol Sci. 2008;29(7):363–371.
47. Koster R, Anderson M, De Beer EJ. Acetic acid–induced writhing test for analgesics. Fed Proc. 1959;18:412–417.
48. Rainsford KD. Anti-inflammatory drugs in the treatment of pain. Pain Rev. 2000;7:213–245.
49. Rates SMK. Plants as source of drugs. Toxicon. 2001;39(5):603–613.
50. Abel SR. (1995); Tramadol: an alternative analgesic to traditional opioids and NSAIDs; Journal of Pharmaceutical Care in Pain & Symptom Control; 3(1); 5-29 
51. Calixto JB, et al. Naturally occurring antinociceptive substances. Pharmacol Rev.2000; 52(3):319-370.
52. McGettigan P, Henry D. Cardiovascular risk with NSAIDs. BMJ. 2011;342:c7086.
53. Bannuru RR, et al. Comparative effectiveness of analgesics in osteoarthritis. Ann Intern Med. 2015;162(1):46-54.           
54. Barnes J, Anderson LA, Phillipson JD. Herbal medicines: A guide for healthcare professionals. Pharm Press. 2013.
55. Calixto JB. Efficacy, safety, quality control of herbal medicines. J Ethnopharmacol. 2000;72(1-2):1-16.
56. Rates SMK. Plants as source of drugs. Toxicon. 2001;39(5):603-613.
57. WHO. WHO guidelines on safety monitoring of herbal medicines. Geneva: World Health Organization; 2004.
58. J Ethnopharmacol. 2000;72(1–2):1–16.
59. Ernst E. Herbal medicines in pain management.Pain. 2007;127(3):185–187.